The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England Journal of Medicine.Metabolic dysfunction-associated steatotic liver disease — previously known as nonalcoholic fatty liver disease — affects about...